Date Filed | Type | Description |
10/12/2023 |
8-K
| Quarterly results |
08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/16/2023 |
4
| DeRosa Anthony John (Chief Revenue Officer) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 10,000 shares
@ $7.72, valued at
$77.2k
Exercised 10,000 options to buy
@ $0.42, valued at
$4.2k
|
|
08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/10/2023 |
8-K
| Quarterly results |
08/03/2023 |
4
| DeRosa Anthony John (Chief Revenue Officer) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 10,000 shares
@ $6.44, valued at
$64.4k
Exercised 10,000 options to buy
@ $0.42, valued at
$4.2k
|
|
08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/18/2023 |
4
| Ellenbogen Michael (Founder & Chief Innovation Ofc) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 83,334 shares
@ $6.74, valued at
$561.7k
|
|
07/17/2023 |
4
| DeRosa Anthony John (Chief Revenue Officer) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 10,000 shares
@ $6.04, valued at
$60.4k
Exercised 10,000 options to buy
@ $0.42, valued at
$4.2k
|
|
07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/05/2023 |
4
| DeRosa Anthony John (Chief Revenue Officer) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 10,000 shares
@ $5.97, valued at
$59.7k
Exercised 10,000 options to buy
@ $0.42, valued at
$4.2k
|
|
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/05/2023 |
4
| Donohue Mark (CFO) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 158,991 shares
@ $5.84, valued at
$928.5k
Exercised 366,935 restricted stock units
@ $0 |
|
06/02/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/31/2023 |
4
| Sullivan Mark J. (Director) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Exercised 48,494 restricted stock units
@ $0 Granted 25,846 restricted stock units
@ $0 |
|
05/31/2023 |
4
| Sheehy Kimberly H. (Director) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Exercised 48,494 restricted stock units
@ $0 Granted 25,846 restricted stock units
@ $0 |
|
05/31/2023 |
4
| Glat Neil (Director) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Exercised 48,494 restricted stock units
@ $0 Granted 25,846 restricted stock units
@ $0 |
|
05/31/2023 |
4
| Saintil Merline (Director) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Exercised 48,494 restricted stock units
@ $0 Granted 25,846 restricted stock units
@ $0 |
|
05/31/2023 |
4
| Charlton Kevin M. (Director) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Granted 25,846 restricted stock units
@ $0 |
|
05/19/2023 |
4
| COHEN ALAN S (Director) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Exercised 57,161 options to buy
@ $0.42, valued at
$24k
|
|
05/19/2023 |
4
| Charlton Kevin M. (Director) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Bought 5,000 shares
@ $5.69, valued at
$28.5k
|
|
05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/15/2023 |
4
| Chitkara Anil (Founder & Chief Growth Officer) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 50,000 shares
@ $5, valued at
$250k
Exercised 50,000 options to buy
@ $0.24, valued at
$12k
|
|
05/15/2023 |
4
| Ellenbogen Michael (Founder & Chief Innovation Ofc) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 83,332 shares
@ $5.01, valued at
$417.5k
|
|
05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/10/2023 |
4
| Ellenbogen Michael (Founder & Chief Innovation Ofc) has filed a Form 4 on Evolv Technologies Holdings, Inc.
Txns:
| Sold 800 shares
@ $4, valued at
$3.2k
Sold 82,532 shares
@ $4.03, valued at
$332.6k
|
|
05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/10/2023 |
8-K
| Quarterly results |
05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/13/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/13/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|